ExploreIterate

Isaac Kohlberg

Non-Executive Director

Isaac Kohlberg has had a distinguished career protecting and commercializing IP for leading universities and research institutions. He currently is a Senior Associate Provost and Chief Technology Development Officer at Harvard University, where he responsible for the strategic management and commercial development of all technologies and intellectual property (IP) arising from Harvard’s research enterprise. Mr. Kohlberg’s role at Harvard University includes industry liaising and outreach, IP management, business development, technology commercialization and the formation of startup companies and new ventures around Harvard technology platforms. In tandem, he is also responsible for generating, structuring, and negotiating research alliances and collaborations with industry and generating industry-sponsored research funding for Harvard faculty.


Isaac has served as a Director at Anchiano Therapeutics Ltd (TLV: ANCN, NASDAQ: ANCN), a pivotal-stage biopharmaceutical company, since 2017 and as a Director at Clal Biotechnology Industries Ltd. (TLV: CBI), a life sciences investment company, since 2015. Mr. Kohlberg received his M.B.A. from INSEAD and LL.B. from Tel Aviv University.


Isaac is Chair of the Strategy & Investment Committee and also a member of the Nomination Committee at Arix.

Roles at Arix Bioscience PLC

  • Non-Executive Director

    Current role


My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Arix Bioscience PLC

My pet peeves

My communication style